RxDoctor Payments Data

Stephanie Farmer

Adult Health · Elkton, MDNPI 1427356823

Payments from drug & device makers

$1,888in general payments, 2019–2025

Across 101 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$415
  • Pfizer$282
  • Novo Nordisk$269
  • Astellas Pharma US Inc$224
  • Lilly USA, LLC$211
  • Exact Sciences$156
  • plus $333 from 8 others

What the payments were for

  • Food & beverage$1,78094%
  • Education$1086%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,888 in reported general payments places this provider in the 80th percentile of 542 adult health providers in Maryland.

See all adult health providers in Maryland

Medicare billing

Part B allowed, 2024
$97,633
Medicare patients
241
Services billed
1,291

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol40$59,620
JardianceEmpagliflozin31$38,660
OzempicSemaglutide28$34,211
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$14,715
RybelsusSemaglutide13$12,390
ArexvyRsvpref3 Antigen/As01e/Pf16$5,117
Atorvastatin Calcium190$2,839
Rosuvastatin Calcium83$2,764
ShingrixVaricella-Zoster Ge/As01b/Pf12$2,620
Losartan Potassium126$1,747
Metoprolol Succinate56$1,430
SynthroidLevothyroxine Sodium32$1,384
Amlodipine Besylate154$1,381
Pantoprazole Sodium47$1,275
Albuterol Sulfate HfaAlbuterol Sulfate30$1,221

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$415$59,62040 claims
Novo NordiskOzempic, Rybelsus$269$46,60141 claims
GSKTrelegy Ellipta, Arexvy, Shingrix$14$22,45245 claims
AbbVieSynthroid$112$1,38432 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 542 adult health providers in Maryland.

Other adult health in Elkton

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →